GovChime
Notice ID: 4ec40975a68a448bbdd2c39309226e8cSpecial Notice

Q301--Notice of Intent to Sole Source - ExoDX Prostate Intelliscore Testing - 5 Year BPA

Archived on August 23, 2023. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
3:00 PM UTC−04:00
Posted
July 17, 2023
Notice type
Special Notice

Notice details

Office
241-NETWORK CONTRACT OFFICE 01 (36C241)
Last updated
Dec 6, 2025

Identifiers

Solicitation number
36C24123Q0897
Notice ID
4ec40975a68a448bbdd2c39309226e8c

Description

The Department of Veterans Affairs (VISN1) hereby announces its intent to enter into a 5-year Sole Source Blanket Purchase Agreement (BPA) with EXOSOME DIAGNOSTICS, INC., 266 SECOND AVE, STE 200, WALTHAM, MA 02451-1167. This notice is not a request for quotes, but rather a notice of intent to conduct a sole source procurement in accordance with FAR 6.302-1; only one responsible source and no other supplies or services will satisfy agency requirements. The applicable North American Industry Classification System (NAICS) code is 621511, with a size standard of $36.5M. "ExoDx Prostate Test (Intelliscore) is a non-DRE urinebased liquid biopsy test indicated for men 50 years of age and older with a PSA 2 10 ng/mL being considered for an initial prostate biopsy. A patient-specific risk score is calculated based on a proprietary algorithm that combines the weighted expression of a three-gene signature in exosomal RNA. A score above the cut point is associated with an increased likelihood of GS 7 PCa on subsequent biopsy. Physicians can utilize the result in conjunction with other standard of care prognostic information to determine whether to proceed with a tissue biopsy." YR 1 Testing - CLIN 0001: Item: ExoDX Prostate (Intelliscore) Manufacturer: Exosome Diagnostics, Inc. SIN# 621-200 CPT Code: 0005U Estimated Qty: 360 Unit of Issue: Year YR 2 Testing - CLIN 0002: Item: ExoDX Prostate (Intelliscore) Manufacturer: Exosome Diagnostics, Inc. SIN# 621-200 CPT Code: 0005U Estimated Qty: 360 Unit of Issue: Year YR 3 Testing - CLIN 0003: Item: ExoDX Prostate (Intelliscore) Manufacturer: Exosome Diagnostics, Inc. SIN# 621-200 CPT Code: 0005U Estimated Qty: 360 Unit of Issue: Year YR 4 Testing - CLIN 0004: Item: ExoDX Prostate (Intelliscore) Manufacturer: Exosome Diagnostics, Inc. SIN# 621-200 CPT Code: 0005U Estimated Qty: 360 Unit of Issue: Year YR 5 Testing - CLIN 0005: Item: ExoDX Prostate (Intelliscore) Manufacturer: Exosome Diagnostics, Inc. SIN# 621-200 CPT Code: 0005U Estimated Qty: 360 Unit of Issue: Year Interested parties may identify their interests and capabilities by responding to this requirement by the due date listed on this notice. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. A determination by the Government not to compete this proposed award upon response to this notice is solely within the discretion of the Government. No reimbursement for any cost connected with providing capability information will be provided.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:36C24123Q0897
  1. Special NoticeCurrentJul 17, 2023

    Q301--Notice of Intent to Sole Source - ExoDX Prostate Intelliscore Testing - 5 Year BPA

    Notice 4ec40975a68a448bbdd2c39309226e8c on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

36C24123Q0897

Archive Date

Aug 23, 2023

Office Address

TOGUS, ME, 04330